Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: Common and distinct features

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 8, 1996, Pages 2854-2864

  Morales, A J ^a,c   Laughlin, G A ^a   Butzow T ^a   Maheshwari, H ^b   Baumann, G ^b   Yen, S S C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c General Clinical Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; GROWTH HORMONE RELEASING FACTOR; HYDROXYPROGESTERONE; INSULIN; LUTEINIZING HORMONE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; TESTOSTERONE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LUTEINIZING HORMONE RELEASE; OBESITY; OVARY POLYCYSTIC DISEASE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; STEROIDOGENESIS;

ADOLESCENT; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CIRCADIAN RHYTHM; FEMALE; GONADAL STEROID HORMONES; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; LUTEINIZING HORMONE; OBESITY; POLYCYSTIC OVARY SYNDROME; PULSATILE FLOW; REFERENCE VALUES;

EID: 0029833087     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.8.2854     Document Type: Article

References (70)

1. Adashi EY, and Rohan M. 1992 Intraovarian regulation peptidergic signaling systems. Trends Endocrinol Metab. 3:243 - 248.
2. Giudice LC. 1995 The insulin-like growth factor system in normal and abnormal human ovarian follicle development. Am J Med. 98:48S - 54S.
3. Yen SSC, Laughlin GA, Morales AJ. 1993 Interface between extra- and intraovarian factors in polycystic ovarian syndrome. Proc NY Acad Sci. 687:98.
4. Barbieri RL, Smith S, Ryan KJ. 1988 The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil Steril. 50:197 - 203.
5. Stuart CA, Nagamani M. 1990 Insulin infusion acutely augments ovarian androgen production in normal women. Fertil Steril. 54:788 - 792.
6. Stuart CA, Prince MJ, Peters EJ, et al. 1987 Hyperinsulinemia and hyperandrogenism: in vivo androgen response to insulin infusion. Obstet Gynecol. 69:921 - 925.
7. Pasquali R, Casimirri F. 1993 The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women. Clin Endocrinol (Oxf). 39:1 - 16.
8. Nestler JE, Clore JN, and Blackard WG. 1989 The central role of obesity (hyperinsulinemia) in the pathogenesis of the polycystic ovary syndrome. Am J Obstet Gynecol. 161:1095.
9. Barreca A, Artini PG, DelMonte P, et al. 1993 In vivo and in vitro effects of growth hormone on estradiol secretion by human granulosa cells. J Clin Endocrinol Metab. 77:61 - 67.
10. Mason HD, Martikainen H, Beard RW, Anyaoku V, Franks S. 1990 Direct gonadotrophic effect of growth hormone on oestradiol production by human granulosa cells in vitro. J Endocrinol 126:R1 - R4.
11. Katz E, Ricciarelli E, Adashi E. 1993 The potential of growth hormone to female reproductive physiology and pathophysiology. Fertil Steril. 59:8 - 34.
12. Sharara FI, Nieman LK. 1994 Identification and cellular localization of growth hormone receptor gene expression in the human ovary. J Clin Endocrinol Metab. 79:670 - 672.
13. El-Roeiy A, Chen X, Roberts VJ, LeRoith D, Roberts CT, Yen SSC. 1993 Expression of the insulin-like growth factor (IGF)-I and IGF-II and the IGF-I, IGF-II and insulin receptor genes and localization of the gene products in the human ovary. J Clin Endocrinol Metab. 77:1411 - 1418.
14. Zhou J, and Bondy C. 1993 Anatomy of the human ovarian insulin-like growth factor system. Biol Reprod. 48:467 - 482.
15. El-Roeiy A, Roberts VJ, Shimasaki S, et al. 1994 Expression of the gene encoding the insulin-like growth factors (IGF-I and IGF-II), the IGF and insulin receptors and IGF binding proteins (IGFBPs 1-6), and the localization of their gene products in normal and polycystic ovary syndrome ovaries. J Clin Endocrinol Metab. 78:1488 - 1496.
16. Yen SSC. 1980 The polycystic ovary syndrome. Clin Endocrinol (Oxf). 12:177.
17. Franks S. 1989 Polycystic ovary syndrome: a changing perspective. Clin Endocrinol (Oxf). 31:87 - 120.
18. Kopelman PG. 1994 Hormones and obesity. Clin Endocrinol Metab. 8:549 - 575.
19. Grulet H, Hecart AC, Delemer B, et al. 1993 Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome. Clin Endocrinol (Oxf). 38:621 - 626.
20. Holte J, Bergh T, Gennarelli G, Wide L. 1994 The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women. Clin Endocrinol (Oxf). 41:473 - 481.
21. Laatikainen T, Tulenheimo A, Andersson B, Karkkainen J. 1983 Obesity, serum steroid levels, and pulsatile gonadotropin secretion in polycystic ovarian disease. Eur J Obstet Gynecol Reprod Biol. 15:45 - 53.
22. Dale PO, Tanbo T, Vaaler S, Abyholm T. 1992 Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations. Fertil Steril. 58:487 - 491.
23. Poretsky L. 1994 Insulin resistance and yperandrogenism: update 1995. Endoer Rev. 2:125 - 129.
24. Antilla L, Koskinen P, Jaatinen TA, et al. 1993 Insulin hypersecretion together with high luteinizing hormone concentrations augments androgen secretion in oral glucose tolerance test in women with polycystic ovarian disease. Hum Reprod. 8:1179 - 1183.
25. Kazer RR, Unterman TG, Glick RP. 1990 An abnormality of the growth hormone/insulin-like growth factor I axis in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 71:958 - 962.
26. Prevelic GM, Wurzburger MI, Balint-Peric I, Ginsburg J. 1992 Twenty-four hour serum growth hormone, insulin, C-peptide and blood glucose profiles and serum insulin-like growth factor-1 concentrations in women with polycystic ovaries. Horm Res. 37:125 - 131.
27. Insler V, Barash A, Shohanm A, et al. 1994 Overnight secretion pattern of growth hormone, sex hormone binding globulin, insulin-like growth factor-I and its binding protein in obese and non-obese women with polycystic ovarian disease. Isr J Med Sci. 30:42 - 47.
28. Slowinska-Srzednicka J, Zgliczynski W, Makowska A, et al. 1992 An abnormality of the growth hormone/insulin-like growth factor-1 axis in women with polycystic ovary syndrome due to coexistent obesity. J Clin Endocrinol Metab. 74:1432 - 1435.
29. Poison DW, Wadsworth J, Adams J, Franks S. 1988 Polycystic ovaries: a common finding in normal women. Lancet. 1:870 - 872.
30. Dunaif A, Sorbara L, Delson R, Green G. 1993 Ethnicity and polycystic ovary syndrome are associated with independent and additive decreases in insulin action in Caribbean-Hispanic women. Diabetes. 42:1462 - 1468.
31. Osei K, Schuster DP. 1994 Ethnic differences in secretion, sensitivity and hepatic extraction of insulin in black and white Americans. Diabetes Med. 11:755 - 762.
32. Berga SL, Yen SSC. 1989 Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 30:177 - 84.
33. Steil GM, Volund A, Kahn SE, Bergman RN. 1993 Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model. Diabetes. 42:250 - 256.
34. Bergman RN, Beard JC, Chen M. 1986 The minimal modeling method. Assessment of insulin sensitivity and beta-cell function in vivo. In: Clarke WL, Larner J, Pohl SL, eds. Methods in diabetes research. New York: Wiley and Sons. 15 - 34.
35. Yen SSC, Samaan N, Pearson O. 1967 Growth hormone levels in pregnancy. J Clin Endocrinol Metab. 27:1341 - 1345.
36. Loucks AB, Mortola JF, Girton L, Yen SSC. 1989 Alterations in the hypothalamic-pituitary-ovarian and the hypothalamic-pituitary-adrenal axes in athletic women. J Clin Endocrinol Metab. 68:402 - 411.
37. Holden JP, Bützow TL, Laughlin GA, Ho M, Morales AJ, Yen SSC. 1995 Regulation of insulin-like growth factor binding protein-1 (IGFBP-1) during the 24h metabolic clock and in response to hypoinsulinemia induced by fasting and Sandostatin in normal women. J Soc Gynecol Invest. 2:38 - 44.
38. Anderson DC, Hopper BR, Lasley BL, Yen SSC. 1976 A simple method for assay of eight steroids in small volumes of plasma. Steroids. 28:179 - 196.
39. Ho KKY, Valiontis E, Waters MJ, Rajkovic IA. 1993 Regulation of growth hormone binding protein in man: comparison of gel chromotgraphy and immunoprecipitation methods. J Clin Endocrinol Metab. 76:302 - 308.
40. Veldhuis JD, Johnson ML. 1986 Cluster analysis: a simple, versatile and robust algorithm for endocrine pulse detection. Am J Physiol. 250:E486 - E490.
41. Dunaif A, Segal KR, Shelley DR, et al. 1992 Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes. 41:1257 - 1266.
42. Ciaraldi TP, El-Roeiy A, Madar Z, Reichert D, Olefsky JM, Yen SSC. 1992 Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab. 75:577 - 583.
43. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 38:1165.
44. O'Meara NM, Blackman JD, Ehrmann DA, et al. 1993 Defects in beta-cell function in functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 76:1241 - 1247.
45. Dunaif A, Finegood DT. 1996 β-Cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab. 81:942 - 947.
46. Ovesen P, Moller J, Ingerslev HJ, et al. 1993 Normal basal and insulinstimulated fuel metabolism in lean women with the polycystic ovary syndrome. J Clin Endocrinol Metab. 77:1636 - 1640.
47. Holte J, Bergh T, Berne C, Berglund L, Lithell J. 1994 Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J Clin Endocrinol Metab. 78:1052 - 1058.
48. Chang RJ, Nakamura RM, Judd HL, Kaplan SA. 1983 Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab. 57:356.
49. Shoupe D, Kumar DD, Lobo RA. 1983 Insulin resistance in polycystic ovary syndrome. Am J Obstet Gynecol. 147:588 - 592.
50. Bergh C, Carlsson B, Olsson JH, et al. 1993 Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin. Fertil Steril. 59:323 - 331.
51. Gilling-Smith C, Wills DS, Mason HD, Franks S. 1994 Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. J Clin Endocrinol Metab. 79:1158 - 1165.
52. Nahum R, Thong KJ, Hillier SG. 1995 Metabolic regulation of androgen production by human thecal cells in vitro. Hum Reprod. 10:75 - 81.
53. Garzo VG, Dorrington JH. 1984 Aromatase activity in human granulosa cells during follicular development and the modulation by follicle stimulating hormone and insulin. Am J Obstet Gynecol. 148:657 - 662.
54. Erickson GF, Magoffin DA, Cragun JF, Chang RJ. 1990 The effects of insulin and insulin-like growth factors-1 and II on estradiol production by granulosa cells of polycystic ovaries. J Clin Endocrinol Metab. 70:894 - 902.
55. Burghen GA, Givens JR, Kitabchi AE. 1983 Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab. 50:113.
56. Nestler JE, Barlascini CO, Matt DW, Steingold KA, et al. 1989 Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 72:83 - 89.
57. Kiddy DS, Hamilton-Fairley D, Bush A, et al. 1992 Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 36:105 - 111.
58. Holte J, Bergh R, Berne C, Wide L, Lithell J. 1995 Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 80:2586 - 2593.
59. Apter D, Butzow T, Laughlin GA, Yen SSC. 1994 Accelerated 24h LH pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome. J Clin Endocrinol Metab. 79:119 - 125.
60. Apter D, Butzow T, Laughlin GA, Yen SSC. 1995 Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism. J Clin Endocrinol Metab. 80:2966 - 2973.
61. Baumann G. 1994 Growth hormone-binding proteins: state of the art. J Endocrinol. 141:1 - 6.
62. Suikkari AM, Koivisto VA, Koistinen R, Seppala M, Yki-Jarvinen H. 1989 Dose-response characteristics for supppression of low molecular weight plasma insulin-like growth factor-binding protein by insulin. J Clin Endocrinol Metab. 68:135 - 140.
63. Cohen P, Fielder PJ, Hasegawa Y, Frisch H, Giudice LC, Rosenfeld RG. 1991 Clinical aspects of insulin-like growth factor binding proteins. Acta Endocrinol (Copenh). 124:74 - 85.
64. Yen SSC, Vela P, Rankin J. 1970 Inappropriate secretion of follicle-stimulating hormone and luteinizing hormone in polycystic ovarian disease. J Clin Endocrinol Metab. 30:435 - 442.
65. Rebar R, Judd HL, Yen SSC, Rakoff J, VandenBerg G, Naftolin F. 1976 Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest. 57:1320 - 1329.
66. Burger CW, Korsen T, van Kessel H, van Dop PA, Caron FJM, Schoemaker J. 1985 Pulsatile luteinizing hormone patterns in the follicular phase of the menstrual cycle, polycystic ovarian disease (PCOD) and non-PCOD secondary amenorrhea. J Clin Endocrinol Metab. 61:1126 - 1132.
67. Waldstreicher J, Santoro NF, Hall JE, Filicori M, Crowley Jr WF. 1988 Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization. J Clin Endocrinol Metab. 66:165 - 172.
68. Imse V, Holzapfel G, Hinney B, Kuhn W, Wuttke W. 1992 Comparison of luteinizing hormone pulsatility in the serum of women suffering from polycystic ovarian disease using a bioassay and five different immunoassays. J Clin Endocrinol Metab. 74:1053 - 1061.
69. Mortola JF, Sathanandan M, Kolterman O, Yen SSC. Insulin modulates gonadotropin release and gonadotrope sensitivity to GnRH in polycystic ovary syndrome and normal women [Abstract 420]. Proc of the Soc for Gynecol Invest. 1989;291.
70. Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DF, Sheikh Z. 1992 Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med. 327:157 - 162.